What is the current size of the photodynamic therapy devices market?

As of 2027 the market size of photodynamic therapy devices is valued at USD 767.33 million.

How is the photodynamic therapy devices industry size expected to evolve during the forecast period?

Photodynamic Therapy Devices Market size was around USD 717.4 million in 2026 and is slated to grow at a 8.27% CAGR from 2027 to 2036, reaching USD 1.59 billion by 2036.

How is the rising prevalence of skin cancer influencing adoption priorities in the photodynamic therapy devices market?

It is driving greater preference for minimally invasive, outpatient PDT procedures that effectively treat superficial lesions while reducing scarring and recovery time, leading dermatology and oncology providers to expand device adoption in office-based care settings.

How is the expansion of cosmetic dermatology applications affecting utilization of photodynamic therapy systems?

Growing use in acne, photorejuvenation, and aesthetic skin treatments is broadening PDT demand beyond oncology, prompting clinics and medispas to invest in versatile light-based systems to support recurring, non-surgical treatment offerings.

Why do diode lasers dominate the photodynamic therapy devices market?

Diode Lasers held a 73.13% share in 2026 due to their dependable light delivery, broad clinical familiarity, and seamless integration into established photodynamic therapy workflows, supporting consistent treatment execution.

Which end-use segment is growing fastest in the photodynamic therapy devices market?

Clinics and Dermatology Centers are the fastest-growing end-use segment, driven by increasing demand for specialized outpatient treatment settings that offer convenience and streamlined patient flow.

Why does North America lead the photodynamic therapy devices market?

North America leads with 40.64% share due to advanced treatment adoption in specialty care, strong clinical awareness, and broad access to specialized practitioners and procedure-based workflows.

What is driving growth in the Asia Pacific photodynamic therapy devices market?

Asia Pacific is expanding at 10.06% CAGR driven by widening treatment access, improving clinical capabilities, and increasing adoption of minimally invasive device-based therapies in hospitals and specialty care.

Who are the leading players in the photodynamic therapy devices landscape?

Key players in the photodynamic therapy devices market include Boston Scientific Corporation (United States), biolitec AG (Germany), Lumibird Medical (France), ShangHai Apolo Medical Technology Co., Ltd. (China), Coherent Corp. (United States), Modulight USA Inc. (Finland), IRIDEX Corporation (United States), Candela Corporation (United States), Cutera, Inc. (United States), Excel Lasers (China).